Cargando…

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making

BACKGROUND: Several economic obstacles can deter the development and use of vaccines. This can lead to limited product options for some diseases, delays in new product development, and inequitable access to vaccines. Although seemingly distinct, these obstacles are actually interrelated and therefor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutubessy, Raymond, Lauer, Jeremy A., Giersing, Birgitte, Sim, So Yoon, Jit, Mark, Kaslow, David, Botwright, Siobhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318807/ https://www.ncbi.nlm.nih.gov/pubmed/37400797 http://dx.doi.org/10.1186/s12916-023-02929-0

Ejemplares similares

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2020)

‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation
por: Archer, Rachel A., et al.
Publicado: (2020)

What Drives the Value of a Shigella Vaccine?
por: Hausdorff, William P., et al.
Publicado: (2022)

Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects
por: Botwright, Siobhan, et al.
Publicado: (2017)

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015()
por: Giersing, Birgitte K., et al.
Publicado: (2016)

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
por: Botwright, Siobhan, et al.
Publicado: (2020)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
por: Modjarrad, Kayvon, et al.
Publicado: (2016)

Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016
por: Giersing, Birgitte K., et al.
Publicado: (2019)

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

A Framework for Assessing the Value of Investments in Nonclinical Prevention
por: Miller, George, et al.
Publicado: (2015)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
por: Jit, Mark
Publicado: (2021)

Evolving pharmacovigilance requirements with novel vaccines and vaccine components
por: Zuber, Patrick L F, et al.
Publicado: (2021)

Planning for future COVID-19 vaccine procurement
por: Teerawattananon, Yot, et al.
Publicado: (2022)

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future
por: Standaert, Baudouin, et al.
Publicado: (2020)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

A perspective on the assessment of the broad value of vaccinations
por: de Waure, C, et al.
Publicado: (2022)

Value investing: tools and techniques for intelligent investment
por: Montier, James
Publicado: (2009)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
por: Hosangadi, Divya, et al.
Publicado: (2019)

Value investing in Asia: the definitive guide to investing in Asia
por: Peir Shenq, Lim, et al.
Publicado: (2017)

The broader economic impact of vaccination: reviewing and appraising the strength of evidence
por: Jit, Mark, et al.
Publicado: (2015)

All about value investing
por: Faerber, Esme
Publicado: (2014)

The Investment (?) Value of Life Insurance
Publicado: (1917)

Lack of Investment Value of Insurance
Publicado: (1915)

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
por: Giersing, Birgitte K, et al.
Publicado: (2023)

Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines
por: Forman, Rebecca, et al.
Publicado: (2020)

The Value of Vaccination
Publicado: (1920)

The Value of Vaccination
Publicado: (1884)

Value of Vaccination
Publicado: (1879)

Value of Vaccination
Publicado: (1873)

Value of Vaccination
Publicado: (1893)

Strategic value investing: practical techniques of leading value investors
por: Horan, Stephen, et al.
Publicado: (2014)

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
por: Hutubessy, Raymond, et al.
Publicado: (2011)

150 Engagement to Reduce COVID-19 Vaccine Hesitancy - The Value of Investments In Long Term Community Relationships
por: Nease, Donald, et al.
Publicado: (2022)

Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward
por: Bell, Eleanor, et al.
Publicado: (2021)

Placing a value on increased flexible vaccine manufacturing capacity for future pandemics
por: Newall, Anthony T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vl5katjv45f75jdht6bbr42lt2